סך נכסי הפעילות העסקית Relmada Therapeutics Inc (RLMD)
The price trend for the total assets of Relmada Therapeutics (RLMD) reflected in this chart is 120.09. Business efficiency relies on strict temperature control during the delivery of neuropreparations to preserve their properties. The development strategy is based on testing NMDA receptor blockers in various modes, which minimizes regulatory threats. Meanwhile, anticipation of the final trial results for the antidepressant will become a key growth driver, despite past failures.
פילוחים אנליטיים של חברת Relmada (RLMD)
This indicator represents a market valuation of the company's resources, calculated inversely via daily ROA based on current quotes, which allows for the analysis of future asset potential. By analyzing the trajectory of total balance sheet assets, an investor can assess the capitalization of the intellectual capital of Relmada Therapeutics (RLMD), which is supported by a stable staff of leading neurobiologists creating value through the development of innovative antidepressants.